cetylpyridinium chloride anhydrous has been researched along with Venous Thrombosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bank, I; Bossuyt, PM; Hamulyák, K; Locadia, M; Middeldorp, S; Prins, MH; Sprangers, MA; Stalmeier, PF; van der Meer, J; van Dongen, CJ | 1 |
1 other study(ies) available for cetylpyridinium chloride anhydrous and Venous Thrombosis
| Article | Year |
|---|---|
Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Attitude to Health; Female; Health; Health Status Indicators; Humans; Male; Middle Aged; Quality of Life; Thromboembolism; Venous Thrombosis; Vitamin K | 2004 |